- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02203747
Patient Perception of Visual Distortions
November 18, 2015 updated by: Abbott Medical Optics
The purpose of this study is to evaluate visual distortions reported by pseudophakic patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
79
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Santa Ana, California, United States, 92705
- Contact AMO for Trial Locations
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
22 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Bilaterally-implanted pseudophakic subjects over 22 years of age with astigmatism who meet the inclusion criteria.
Description
Inclusion Criteria:
- Corneal astigmatism of at least 0.75 diopters
- Bilaterally-implanted with monofocal toric intraocular lenses in both eyes or with monofocal non-toric intraocular lenses in both eyes
- At least one month postoperative from second-eye surgery
- Ability to understand, read and write English to give consent and complete study questionnaire
- Availability, willingness, and sufficient cognitive awareness to comply with examination procedures and study visits
- Sign informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization
- Other protocol-defined inclusion criteria may apply
Exclusion Criteria:
- Any ocular pathology of clinical significance, as determined by the investigator, other than regular corneal astigmatism, that may affect visual outcomes or influence subjective ocular visual symptoms
- Patient is pregnant or is lactating
- Participation in any other clinical trial during the last 30 days prior to study enrollment or concurrent participation in any other ongoing clinical trial
- Other protocol-defined exclusion criteria may apply
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Pseudophakic implanted with toric IOL
Subjects bilaterally implanted with toric IOL
|
|
Pseudophakic implanted with non-toric IOL
Subjects bilaterally implanted with non-toric IOL
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Distortion Symptoms
Time Frame: Baseline
|
Subjective rating of visual distortion symptoms under overall conditions at baseline.
Rating scale consisted of the following categories: "did not experience" (rating = 0), "mild" (rating = 1), "moderate" (rating = 2), or "severe" (rating = 3), therefore, the lower values represent the best outcome.
The minimum score was 0 and the maximum score was 3.
|
Baseline
|
Visual Distortion Symptoms
Time Frame: 1 week
|
Subjective rating of visual distortion symptoms under overall conditions at baseline.
Rating scale consisted of the following categories: "did not experience" (rating = 0), "mild" (rating = 1), "moderate" (rating = 2), or "severe" (rating = 3), therefore, the lower values represent the best outcome.
The minimum score was 0 and the maximum score was 3.
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2014
Primary Completion (Actual)
October 1, 2014
Study Completion (Actual)
January 1, 2015
Study Registration Dates
First Submitted
July 10, 2014
First Submitted That Met QC Criteria
July 28, 2014
First Posted (Estimate)
July 30, 2014
Study Record Updates
Last Update Posted (Estimate)
December 22, 2015
Last Update Submitted That Met QC Criteria
November 18, 2015
Last Verified
September 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TIOL-201-VPAS
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract
-
Fundación Pública Andaluza para la Investigación...CompletedCataract | Cataract Mature | Cataract, Nuclear
-
Johannes Kepler University of LinzCompletedCataract Complicated | Cataract Complications OperationsAustria
-
Gemini Eye ClinicRecruitingBilateral Cataract | Unilateral CataractCzechia
-
Universitaire Ziekenhuizen KU LeuvenLaboratoires TheaRecruiting
-
Omer Othman AbdullahCompletedCongenital Cataract | Pediatric CataractIraq
-
Yonsei UniversityCompletedCataract PatientsKorea, Republic of
-
Johannes Kepler University of LinzRecruitingAphakia | Secondary Cataract Surgery | Complicated Cataract SurgeryAustria
-
National University Hospital, SingaporeSingapore General HospitalCompletedCataract Surgery | Stress Levels | Music Improving Outcomes in Cataract SurgerySingapore
-
Advanced Center for Eyecare GlobalNot yet recruiting
-
Vienna Institute for Research in Ocular SurgeryRecruiting
Clinical Trials on Administration of patient self-assessment
-
Abbott Medical OpticsCompleted
-
Ohio State University Comprehensive Cancer CenterRecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
University of California, San FranciscoBristol-Myers Squibb FoundationCompletedStage III Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Malignant Neoplasm | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal... and other conditionsUnited States
-
UMC UtrechtUniversity of Ghana; Korle-Bu Teaching Hospital, Accra, GhanaCompleted
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States, Puerto Rico
-
Mayo ClinicRecruitingMultiple Myeloma | Myelodysplastic Syndrome | Advanced Malignant Solid Neoplasm | Advanced Pancreatic Carcinoma | Hematopoietic and Lymphoid System Neoplasm | Advanced Lung Carcinoma | Advanced Prostate Carcinoma | Advanced Glioblastoma | Advanced Gastric Carcinoma | Advanced Breast Carcinoma | Advanced Colorectal... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingSolid NeoplasmUnited States
-
Fresenius Medical Care Deutschland GmbHacromion GmbH; Vector Psychometric Group, LLCCompletedRenal Failure | End Stage Renal DiseaseTurkey
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | COVID-19 InfectionUnited States
-
Chillicothe VA Medical CenterCompletedPain | Low Back Pain | Musculoskeletal Pain | Chronic Pain | Fibromyalgia | Neuropathic Pain | Chronic Pain Syndrome | Neuropathy, PainfulUnited States